Dynamic interplay between the neutral glycosphingolipid CD77/Gb3 and the therapeutic antibody target CD20 within the lipid bilayer of model B lymphoma cells

Biochem Biophys Res Commun. 2007 Apr 20;355(4):944-9. doi: 10.1016/j.bbrc.2007.02.053. Epub 2007 Feb 21.

Abstract

The centroblast-specific differentiation marker CD77 (Gb(3)), is the receptor for Shiga-like toxin (SLT). The dynamic relationship between Gb(3)/CD77 and key B-cell membrane proteins was studied in Burkitt's lymphoma cells with a focus on CD20. Engagement of Gb(3)/CD77 with SLT-B reduced the amount of CD20 and CXCR4 available, but levels of BCR, MHC Class II, CD21, CD27 and CD54 remained unchanged. Cholesterol depletion promoted a decrease in the number of sites accessed by CD20, CXCR4 and Gb(3)/CD77 antibodies. Constitutive localisation of Gb(3)/CD77 to lipid rafts was unperturbed by either SLT-B binding or cholesterol depletion, whereas the opposite was true for CD20. The effects were specific to SLT-B, highlighted by the inability of cholera toxin B-subunit to alter CD20 availability. Thus, the binding of Gb(3)/CD77 by its cognate ligand transmits information within the lipid bilayer of model lymphoma cells to impact the behaviour of selective proteins, most notably CD20, via a mechanism influenced by the level of cholesterol within the membrane.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / immunology*
  • Antibodies / therapeutic use
  • Antigens, CD20 / immunology*
  • Antigens, CD20 / metabolism
  • Apoptosis / drug effects
  • Biomarkers
  • Burkitt Lymphoma / immunology*
  • Burkitt Lymphoma / metabolism*
  • Burkitt Lymphoma / pathology
  • Cell Line, Tumor
  • Cholera Toxin / pharmacology
  • Humans
  • Lipid Bilayers
  • Membrane Microdomains / drug effects
  • Membrane Microdomains / metabolism
  • Models, Biological*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Shiga Toxins / pharmacology
  • Trihexosylceramides / chemistry
  • Trihexosylceramides / immunology*
  • Trihexosylceramides / metabolism*

Substances

  • Antibodies
  • Antigens, CD20
  • Biomarkers
  • Lipid Bilayers
  • Proto-Oncogene Proteins c-bcl-2
  • Shiga Toxins
  • Trihexosylceramides
  • globotriaosylceramide
  • Cholera Toxin